CDC, States Update Number of Cases of Hospitalized E-cigarette, or Vaping, Product Use Associated Lung Injury (EVALI) | site |




(December 5, 2019) - - Today, the Centers for Disease Control and Prevention (CDC) published the following information:

CDC today announced the updated number of cases* of e-cigarette, or vaping, product use associated lung injury (EVALI).

*As of December 4, 2019, CDC will only report hospitalized EVALI cases, and EVALI deaths regardless of hospitalization status.

Patients with Lung Injury

As of December 4, 2019, 2,291** cases of hospitalized EVALI were reported by all 50 states, the District of Columbia, and 2 U.S. territories (Puerto Rico, and the U.S. Virgin Islands).

Deaths
  • As of December 4, 2019, 48 deaths have been confirmed in 25 states and the District of Columbia:
  1. Alabama, California, Connecticut, Delaware, the District of Columbia, Florida, Georgia, Illinois, Indiana, Kansas, Louisiana, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, New Jersey, New York, Oregon, Pennsylvania, Tennessee, Texas, Utah, and Virginia.
  • More deaths are under investigation.

**Due to only reporting hospitalized EVALI cases as of December 4, 2019, CDC removed 175 nonhospitalized cases from previously reported national case counts.

For updates on this investigation, visit: www.cdc.gov/lunginjury .

For information about the collection of e-cigarette, or vaping, products, including e-liquids, associated with confirmed or probable cases for possible testing by FDA, contact: [email protected] fda.hhs.gov .

For information about collection and submission of clinical specimens for possible testing by CDC, see CDC’s Healthcare Provider web page.

For information about collection and submission of e-cigarette, or vaping, products, including e-liquids, associated with confirmed or probable cases for possible aerosol emissions testing by CDC, contact: [email protected] .

Clinicians and health officials who have questions about this outbreak can contact: [email protected] ov .

All others, including the general public, who have questions about this outbreak can contact CDC-INFO at 800-232-4636, or visit wwwn.cdc.gov/dcs/ContactUs/Form .